Skip to content
healthcare.dev

Erythromycin Ethylsuccinate

NDC 62559-631, Erythromycin Ethylsuccinate, granule, for suspension, from ANI Pharmaceuticals, Inc..

Product NDC
62559-631
Status
Listed
Labeler
ANI Pharmaceuticals, Inc.
Dosage form
GRANULE, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA062055
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62559-631 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ERYTHROMYCIN ETHYLSUCCINATE400 mg/5mL

Pharmacologic classes

Decreased Sebaceous Gland Activity [PE]; Macrolide Antimicrobial [EPC]; Macrolide [EPC]; Macrolides [CS]

Package NDCNDC-11Package
62559-631-0162559063101100 mL in 1 BOTTLE (62559-631-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3d80f96e-3bbe-4fa5-89a8-694c61dd5e8f
  • NADAC price for package 62559063101

    GET /v1/drugs/nadac/62559063101

Use it

Look up 62559-631 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62559-631 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62559-631. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.